| Product Code: ETC6661988 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Neurology Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Neurology Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Neurology Market - Industry Life Cycle |
3.4 Canada Neurology Market - Porter's Five Forces |
3.5 Canada Neurology Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Canada Neurology Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.7 Canada Neurology Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Canada Neurology Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Canada Neurology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Canada |
4.2.2 Technological advancements in neurology diagnostics and treatments |
4.2.3 Growing investment in research and development in the neurology sector |
4.3 Market Restraints |
4.3.1 High cost associated with neurology treatments and procedures |
4.3.2 Limited accessibility to specialized neurology care in certain regions of Canada |
5 Canada Neurology Market Trends |
6 Canada Neurology Market, By Types |
6.1 Canada Neurology Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Canada Neurology Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Canada Neurology Market Revenues & Volume, By Neurodegenerative Diseases, 2021- 2031F |
6.1.4 Canada Neurology Market Revenues & Volume, By Neurovascular Diseases, 2021- 2031F |
6.1.5 Canada Neurology Market Revenues & Volume, By Neuro-infectious Diseases, 2021- 2031F |
6.1.6 Canada Neurology Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Canada Neurology Market, By Procedure |
6.2.1 Overview and Analysis |
6.2.2 Canada Neurology Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.2.3 Canada Neurology Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.2.4 Canada Neurology Market Revenues & Volume, By Parkinson's Disease, 2021- 2031F |
6.2.5 Canada Neurology Market Revenues & Volume, By Alzheimer's Disease, 2021- 2031F |
6.2.6 Canada Neurology Market Revenues & Volume, By Stroke, 2021- 2031F |
6.2.7 Canada Neurology Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Canada Neurology Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Canada Neurology Market Revenues & Volume, By Adult, 2021- 2031F |
6.3.3 Canada Neurology Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.4 Canada Neurology Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Canada Neurology Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Canada Neurology Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Canada Neurology Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.4.5 Canada Neurology Market Revenues & Volume, By Research Institutes, 2021- 2031F |
6.4.6 Canada Neurology Market Revenues & Volume, By Others, 2021- 2031F |
7 Canada Neurology Market Import-Export Trade Statistics |
7.1 Canada Neurology Market Export to Major Countries |
7.2 Canada Neurology Market Imports from Major Countries |
8 Canada Neurology Market Key Performance Indicators |
8.1 Number of neurology clinical trials conducted in Canada |
8.2 Adoption rate of new neurology treatments and technologies in Canadian hospitals |
8.3 Patient satisfaction scores for neurology services |
8.4 Number of neurologists per capita in Canada |
8.5 Percentage of healthcare budget allocated to neurology services in Canada |
9 Canada Neurology Market - Opportunity Assessment |
9.1 Canada Neurology Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Canada Neurology Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.3 Canada Neurology Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Canada Neurology Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Canada Neurology Market - Competitive Landscape |
10.1 Canada Neurology Market Revenue Share, By Companies, 2024 |
10.2 Canada Neurology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here